SEC Filings

SEC Filings

Filing date	Description	Form	Company	View
Mar 03, 2023	Statement of changes in beneficial ownership of securities	4	Surface Oncology	0001209191-23-016048.pdf 0001209191-23-016048.rtf 0001209191-23-016048.xls View HTML
Mar 03, 2023	Statement of changes in beneficial ownership of securities	4	Surface Oncology	0001209191-23-016052.pdf 0001209191-23-016052.rtf 0001209191-23-016052.xls View HTML
Mar 03, 2023	Statement of changes in beneficial ownership of securities	4	Surface Oncology	0001209191-23-016049.pdf 0001209191-23-016049.rtf 0001209191-23-016049.xls View HTML
Mar 03, 2023	Statement of changes in beneficial ownership of securities	4	Surface Oncology	0001209191-23-016050.pdf 0001209191-23-016050.rtf 0001209191-23-016050.xls View HTML
Feb 13, 2023	An amendment to the SC 13G filing	SC 13G/A	Surface Oncology	0000935836-23-000170.pdf 0000935836-23-000170.rtf 0000935836-23-000170.xls View HTML
Feb 10, 2023	An amendment to the SC 13G filing	SC 13G/A	Surface Oncology	0001104659-23-018356.pdf 0001104659-23-018356.rtf 0001104659-23-018356.xls View HTML
Feb 10, 2023	Report of unscheduled material events or corporate event	8-K	Surface Oncology	0001193125-23-032837.pdf 0001193125-23-032837.rtf 0001193125-23-032837.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
Jan 31, 2023	An amendment to the SC 13G filing	SC 13G/A	Surface Oncology	0001104659-23-008286.pdf 0001104659-23-008286.rtf 0001104659-23-008286.xls View HTML
Jan 12, 2023	Report of unscheduled material events or corporate event	8-K	Surface Oncology	0001193125-23-007282.pdf 0001193125-23-007282.rtf 0001193125-23-007282.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
Nov 03, 2022	Initial filing by director officer or owner of more than ten percent.	3	Surface Oncology	0001209191-22-055673.pdf 0001209191-22-055673.rtf 0001209191-22-055673.xls View HTML

Data provided by Kaleidoscope.